Skip to main content
. 2021 Dec 13;85(2):185–194. doi: 10.4046/trd.2021.0123

Fig. 3.

Fig. 3.

Survival of idiopathic pulmonary fibrosis patients diagnosed since 2016. Patients treated with antifibrotics survived longer than those not treated with antifibrotics and those who were treated with antifibrotics for less than three months (p<0.001). No death was observed among untreated patients.